However, a detailed understanding of the specific pro- and anti-angiogenic effects of HO-1, its enzymatic products and downstream target genes in regulating the the angiogenic cascade, for example during wound healing or in pathologies such as chronic inflammatory disease or neoplasms, is essential if therapeutic targeting is ever to be achieved safely2, 55. This evidence concerns the gene HMOX1 and neoplasm.